NO20072210L - Metabolsk aktive mikroorganismer og fremgangsmater for fremstilling derav - Google Patents

Metabolsk aktive mikroorganismer og fremgangsmater for fremstilling derav

Info

Publication number
NO20072210L
NO20072210L NO20072210A NO20072210A NO20072210L NO 20072210 L NO20072210 L NO 20072210L NO 20072210 A NO20072210 A NO 20072210A NO 20072210 A NO20072210 A NO 20072210A NO 20072210 L NO20072210 L NO 20072210L
Authority
NO
Norway
Prior art keywords
preparation
metabolically active
processes
active microorganisms
microorganisms
Prior art date
Application number
NO20072210A
Other languages
English (en)
Inventor
Timothy Thurlby
Original Assignee
Multigerm Uk Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Multigerm Uk Entpr Ltd filed Critical Multigerm Uk Entpr Ltd
Publication of NO20072210L publication Critical patent/NO20072210L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Animal Husbandry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

Oppfinnelsen angår et preparat av metabolsk aktive bakterier, sammensetninger som omfiatter et slikt preparat, fior eksempel probiotiske tilsetninger eller dyrefior og anvendelse av disse, fior eksempel ved behandlingen av sykdommer som påvirker den mikrobielle tarmbalansen. Det er også beskrevet et vekstsubstrat fior mikroorganismer som omfiatter en blanding av komplekse og enkle sukker, fiomten en firemgangsmåte fior fremstillingen av preparater av metabolsk aktive mikroorganismer som bruker dette vekstsubstiatet.
NO20072210A 2004-09-27 2007-04-27 Metabolsk aktive mikroorganismer og fremgangsmater for fremstilling derav NO20072210L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0421448A GB2418431A (en) 2004-09-27 2004-09-27 Metabolically active micro organisms and methods for their production
PCT/GB2005/003715 WO2006035218A1 (en) 2004-09-27 2005-09-27 Metabolically active micro organisms and methods for their production

Publications (1)

Publication Number Publication Date
NO20072210L true NO20072210L (no) 2007-04-27

Family

ID=33397330

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072210A NO20072210L (no) 2004-09-27 2007-04-27 Metabolsk aktive mikroorganismer og fremgangsmater for fremstilling derav

Country Status (14)

Country Link
US (2) US8551473B2 (no)
EP (2) EP3050960B1 (no)
JP (1) JP5577020B2 (no)
CN (2) CN100537740C (no)
AU (1) AU2005288751B2 (no)
CA (1) CA2580949C (no)
EA (1) EA012968B1 (no)
ES (2) ES2654246T3 (no)
GB (1) GB2418431A (no)
NO (1) NO20072210L (no)
NZ (1) NZ553858A (no)
PL (2) PL3050960T3 (no)
WO (1) WO2006035218A1 (no)
ZA (1) ZA200702398B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2418431A (en) 2004-09-27 2006-03-29 Multigerm Uk Entpr Ltd Metabolically active micro organisms and methods for their production
SE532899C2 (sv) 2007-06-08 2010-05-04 Probi Ab Förfarande genom fermentering med Lactobacillus plantarum för tillhandahållande av en insulinsvarsreducerande produkt och dess användning farmaceutiskt eller i livsmedel
EP2347661B1 (en) * 2008-11-21 2019-01-09 José Antonio Cruz Serrano Method for obtaining a mixture of probiotics, nutrient prebiotics having synergistic symbiotic action
GB201119774D0 (en) * 2011-11-16 2011-12-28 Multigerm Uk Entpr Ltd IBS treatment
DK3329927T3 (da) * 2011-11-16 2023-12-11 Multigerm Uk Entpr Ltd IBS-behandling med probiotika
GB201219873D0 (en) * 2012-11-05 2012-12-19 Multigerm Uk Entpr Ltd Diverticulitis treatment
DE102012110612A1 (de) * 2012-11-06 2014-05-08 Gelita Ag Kollagenhydrolysat und dessen Verwendung
CN105296541A (zh) * 2014-07-30 2016-02-03 无限极（中国）有限公司 燕麦发酵液及其制备方法与作为化妆品原料的应用
ES2575828B1 (es) * 2014-12-31 2017-07-07 Universidad De León Empleo de probióticos en el incremento de la fertilidad masculina
GB201501938D0 (en) 2015-02-05 2015-03-25 Multigerm Uk Entpr Ltd Probiotic preparation
WO2019118984A2 (en) 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
CN108315279A (zh) * 2018-04-09 2018-07-24 河南科技大学 一种植物乳杆菌液体制剂的长时间储存方法
SG11202012621VA (en) * 2018-06-19 2021-01-28 4D Pharma Res Ltd Dosage form comprising a live biotherapeutic product
SG11202013008UA (en) * 2018-07-10 2021-02-25 Univ Keio Intestinal microbe having d-psicose-responsive proliferation
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
CA3111795A1 (en) 2018-09-05 2020-03-12 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
CN109486713B (zh) * 2018-12-06 2021-03-09 福建傲农生物科技集团股份有限公司 一种液态复合乳酸杆菌制剂及其制备方法与应用
GB201915144D0 (en) * 2019-10-18 2019-12-04 Multigerm Uk Entpr Ltd Method of promoting SCFA production by gut microbiota
WO2021113850A2 (en) * 2019-12-06 2021-06-10 Nas Bioventures Llc Onsite installation or manufactured product of eco-friendly bacterial compositions, methods and systems for bioremediation in a short duration in different environments
US20230248788A1 (en) * 2020-06-29 2023-08-10 Canbiocin Inc. Compositions and related methods for supporting companion animals with gastrointestinal disorders
CA3238788A1 (en) 2021-11-22 2023-05-25 Eric Michael Schott Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities
GB202210523D0 (en) 2022-07-18 2022-08-31 Multigerm Uk Entpr Ltd Probiotic compositions and therapeutic uses thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB906212A (en) * 1960-08-04 1962-09-19 Lilly Co Eli The antibiotic valacidin and its salts and methods for producing same
US3623956A (en) * 1970-01-21 1971-11-30 Rapidase Sa Soc Preparation of microbial alkaline protease by fermentation with bacillus subtilis, variety licheniformis
US3846397A (en) * 1970-04-06 1974-11-05 J Ernster Process for utilizing barley malt
US4464402A (en) * 1978-04-24 1984-08-07 F.I.N.D. Research Corporation Process for manufacturing a high protein food material
US4275164A (en) * 1979-11-05 1981-06-23 Eastman Kodak Company Process and nutrient medium for growing microorganism
EP0189657B1 (en) * 1984-12-12 1989-03-01 WHITBREAD & COMPANY PLC A brewing process
JPS63273469A (ja) * 1986-12-13 1988-11-10 Kyowa Hakko Kogyo Co Ltd 乳糖資化性を有する新規微生物
DK686187D0 (da) 1987-12-23 1987-12-23 Hansens Chr Bio Syst Veterinaert praeparat
JP2835894B2 (ja) * 1991-07-26 1998-12-14 農林水産省食品総合研究所長 ビフィズス菌増殖促進剤
JPH08259450A (ja) * 1995-03-17 1996-10-08 Nichinichi Seiyaku Kk インターフェロン産生増強剤
IE960360A1 (en) * 1996-05-23 1997-12-31 Valdosa Limited A brewing process
CZ296732B6 (cs) 1996-08-05 2006-05-17 Syngenta Mogen B.V. Zpusob výroby alkoholických nápoju
US6811786B1 (en) 1999-04-01 2004-11-02 Ganeden Biotech, Inc. Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions
FR2777424B1 (fr) * 1998-04-15 2000-06-16 Lesaffre & Cie Levain panaire longue conservation pret a l'emploi
US6420146B1 (en) * 2000-03-30 2002-07-16 Council Of Scientific & Industrial Research Process for the preparation of stable yeast crystals for enhanced production of ethanol
JP4424643B2 (ja) * 2002-02-13 2010-03-03 株式会社バイオバンク 抗真菌剤の製造方法
GB2391554B (en) * 2002-08-06 2005-09-14 Heineken Ireland Ltd A stout manufacturing process
GB2418431A (en) 2004-09-27 2006-03-29 Multigerm Uk Entpr Ltd Metabolically active micro organisms and methods for their production

Also Published As

Publication number Publication date
CN100537740C (zh) 2009-09-09
CN101603021B (zh) 2013-04-24
PL1794283T3 (pl) 2016-10-31
ES2654246T3 (es) 2018-02-12
ZA200702398B (en) 2008-10-29
US20110158949A1 (en) 2011-06-30
AU2005288751A1 (en) 2006-04-06
CN101603021A (zh) 2009-12-16
US20130011368A1 (en) 2013-01-10
EP1794283A1 (en) 2007-06-13
HK1134686A1 (en) 2010-05-07
EP3050960B1 (en) 2017-12-13
JP5577020B2 (ja) 2014-08-20
EA200700613A1 (ru) 2007-10-26
NZ553858A (en) 2009-01-31
GB2418431A (en) 2006-03-29
WO2006035218A1 (en) 2006-04-06
ES2568955T3 (es) 2016-05-05
EA012968B1 (ru) 2010-02-26
CA2580949A1 (en) 2006-04-06
JP2008514582A (ja) 2008-05-08
US8551473B2 (en) 2013-10-08
EP3050960A1 (en) 2016-08-03
AU2005288751B2 (en) 2010-12-23
EP1794283B1 (en) 2016-04-13
CA2580949C (en) 2017-07-25
PL3050960T3 (pl) 2018-05-30
CN101027387A (zh) 2007-08-29
GB0421448D0 (en) 2004-10-27

Similar Documents

Publication Publication Date Title
NO20072210L (no) Metabolsk aktive mikroorganismer og fremgangsmater for fremstilling derav
García et al. In vitro PGPR properties and osmotic tolerance of different Azospirillum native strains and their effects on growth of maize under drought stress
Sonnenschein et al. Global occurrence and heterogeneity of the Roseobacter-clade species Ruegeria mobilis
WO2021203083A3 (en) Composition comprising bacterial strains for improving metabolic health
BR112013024609B1 (pt) composição, e, método para intensificar o crescimento da planta
ATE332639T1 (de) Herbizidzusammensetzung,umfassend herbizide verbindung in säureform und ansäuerndes mittel, applizierverfahren und herstellungsverfahren davon
NO20070091L (no) Sukkerbelegg og fremgangsmate for dette
SE0701440L (sv) Förfarande för modifiering av polyfenolinnehållande växtmaterial och medicinska användningar av de modifierade polyfenolinnehållande växtmaterialen
AU2003212265A1 (en) Dietetic and/or pharmaceutical compositions for human and/or animal use based on probiotic microbial preparations
MY143795A (en) Tetrahydropyridoindole derivatives
WO2005123116A3 (en) Compositions and methods for treating or preventing oxalate-related disease
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
WO2008013987A3 (en) N-alkyl substituted piperazinylmethylquinazolinones and azepanylmethylquinazolinones
EP1602377A4 (en) COMPOSITION WITH BETA-GLUCAN AND OBSTIPATION LENSES THE MEDIUM, IMMUNOPOTENTIATOR AND HAUT HUMIDIFICANT USING THE COMPOSITION
WO2008064345A3 (en) Microorganism killing compounds
Rütschlin et al. One enzyme to build them all: ring-size engineered siderophores inhibit the swarming motility of Vibrio
ZA202202376B (en) Difluorohaloallylamine sulfone derivative inhibitors of lysyl oxidases, methods of preparation, and uses thereof
WO2020024017A9 (en) Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof
Dantur et al. The endophytic strain Klebsiella michiganensis Kd70 lacks pathogenic island-like regions in its genome and is incapable of infecting the urinary tract in mice
WO2001010901A3 (en) Antimicrobial histone h1 compositions, kits, and methods of use thereof
EP3939599A3 (en) Silicate containing compositions and methods of treatment
MX2024002131A (es) Inhibidores de la 17-beta-hidroxisteroide deshidrogenasa tipo 13 y metodos de uso de los mismos.
WO2006128089A3 (en) Compositions and methods for treating tissue
WO2020165057A8 (en) Compositions containing bacillaene producing bacteria or preparations thereof
WO2007076087A3 (en) 3-aryl-substituted quinazolones, and uses thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application